- The Street Sheet
- Posts
- 🍄 Trip Sheet: Clearmind (CMND) hires D.C. lobbying team to fast-track psychedelic therapies
🍄 Trip Sheet: Clearmind (CMND) hires D.C. lobbying team to fast-track psychedelic therapies
Enveric (ENVB) wins USPTO nod for its non-hallucinogenic tryptamine patents, while Cybin (CYBN) gets a bullish $106 price target in new analyst coverage.
Jun 12, 2025
One trade idea here could pay for your subscription 10x.
We don’t cover fluff. We cover ideas that move portfolios. Upgrade now, before you miss your next trade
Upgrade